| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | $30,149,556 | 2,596,861 | FMR LLC | 31 Mar 2025 | |||
| BML Investment Partners, L.P. | 10% | +12% | $9,739,269 | +$1,005,184 | 1,902,201 | +12% | BML Investment Partners, L.P. | 12 Feb 2026 |
| Woodline Partners LP | 7.5% | $15,392,352 | 1,325,784 | Woodline Partners LP | 31 Mar 2025 | |||
| BlackRock, Inc. | 6.8% | +22% | $17,135,284 | +$3,284,072 | 1,213,547 | +24% | BlackRock, Inc. | 30 Sep 2025 |
| PERCEPTIVE ADVISORS LLC | 6.7% | $14,028,758 | 1,208,334 | Perceptive Advisors LLC | 31 Mar 2025 | |||
| VANGUARD GROUP INC | 5.6% | $18,919,737 | 991,429 | The Vanguard Group | 30 Jun 2025 | |||
| BANK OF AMERICA CORP /DE/ | 5.2% | $4,866,857 | 950,558 | BANK OF AMERICA CORP /DE/ | 31 Dec 2025 | |||
| T. Rowe Price Investment Management, Inc. | 0% | -99% | $33,874 | -$22,601,277 | 2,399 | -100% | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 |
As of 31 Dec 2025, 90 institutional investors reported holding 15,332,080 shares of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM). This represents 85% of the company’s total 18,116,200 outstanding shares.
The largest institutional shareholders of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 2,640,802 | -0.9% | 0% | $9,797,376 |
| Alyeska Investment Group, L.P. | 8.9% | 1,614,582 | 0% | 0.02% | $5,990,099 |
| Woodline Partners LP | 7.3% | 1,325,855 | 0% | 0.02% | $4,918,922 |
| BlackRock, Inc. | 7.1% | 1,289,318 | +3.2% | 0% | $4,783,370 |
| VANGUARD GROUP INC | 5.4% | 977,969 | -0.47% | 0% | $3,628,265 |
| BANK OF AMERICA CORP /DE/ | 5.2% | 950,544 | +4024% | 0% | $3,526,518 |
| PERCEPTIVE ADVISORS LLC | 4.6% | 833,333 | 0% | 0.06% | $3,091,665 |
| Ensign Peak Advisors, Inc | 3.1% | 560,169 | +72% | 0% | $2,078,227 |
| BML Capital Management, LLC | 3% | 543,180 | 0% | 1.8% | $2,015,198 |
| PFM Health Sciences, LP | 2.9% | 530,796 | -69% | 0.2% | $1,969,253 |
| Assenagon Asset Management S.A. | 2.8% | 508,414 | +35% | 0% | $1,886,216 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 400,363 | +0.78% | 0% | $1,485,685 |
| STATE STREET CORP | 1.8% | 330,134 | -0.48% | 0% | $1,224,797 |
| NORTHERN TRUST CORP | 1.3% | 232,587 | -1.8% | 0% | $862,898 |
| AQR CAPITAL MANAGEMENT LLC | 1% | 180,363 | +248% | 0% | $669,146 |
| DEUTSCHE BANK AG\ | 0.98% | 177,681 | +158% | 0% | $659,197 |
| MARSHALL WACE, LLP | 0.94% | 170,758 | -59% | 0% | $633,512 |
| DIMENSIONAL FUND ADVISORS LP | 0.87% | 158,352 | +372% | 0% | $587,372 |
| MORGAN STANLEY | 0.77% | 139,719 | -68% | 0% | $518,358 |
| ACADIAN ASSET MANAGEMENT LLC | 0.7% | 127,268 | +27% | 0% | $468,000 |
| Catalio Capital Management, LP | 0.65% | 118,279 | 0% | 0.08% | $438,815 |
| JPMORGAN CHASE & CO | 0.6% | 109,376 | -6% | 0% | $405,785 |
| XTX Topco Ltd | 0.56% | 100,612 | +877% | 0.01% | $373,271 |
| STIFEL FINANCIAL CORP | 0.44% | 79,924 | 0% | $296,516 | |
| UBS Group AG | 0.4% | 73,160 | +0.99% | 0% | $271,424 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 15,332,080 | $56,879,262 | -$38,517,272 | $3.71 | 90 |
| 2025 Q3 | 17,649,176 | $249,202,204 | -$11,456,191 | $14.12 | 96 |
| 2025 Q2 | 18,242,288 | $350,434,222 | +$69,197,262 | $19.21 | 91 |
| 2025 Q1 | 14,676,599 | $162,319,841 | +$162,319,498 | $11.06 | 59 |